retatrutide phase 3 2025 triple agonist glp-1 gip glucagon Diagram showing the mechanism of action of retatrutide retatrutide triple agonist glp-1 gip

Parhizgar, Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (FAERS)Disproportionality Study, J

Abbasi, A

In the Muscle: GLP-1 Increases glycogen production and glucose oxidation.These actions are in favor of weight reduction, decrease in hyperinsulinemia and increase in insulin sensitivity, offering an indirect cardiovascular protection

Usage Differences Between Saxenda and Ozempic Truveta Research compared Saxenda and Ozempic based on prescribing and dispensing rates, patient characteristics and other criteria

Individuals with inflammatory conditions such as psoriasis who also have metabolic comorbidities might experience dual benefits, though dedicated trials in these populations are lacking